Relationship Between Dietary N ε-(carboxymethyl) lysine Intake and Cognitive Function in U.S. Elderly: Data from NHANES 2011-2014

Di Liu¹, Ying Zhang², Ziyan Ren¹, Xuan Wu¹, Wenzhuo Zhang¹, Yu Xia^3, and Zhongxiao Wan^1,

¹Department of Nutrition and Food Hygiene, School of Public Health, Soochow University, 199 Ren'ai Road, Suzhou, 215123, China

²Xiangcheng District Center for Disease Control and Prevention, 55 Middle Road of Yangcheng Hu, Suzhou, Jiangsu, 215131, China

³Departments of Laboratory, Suzhou Center for Disease Control and Prevention, 72 Sanxiang Road, Suzhou, Jiangsu, 215004, China

Cite this paper:
Di Liu, Ying Zhang, Ziyan Ren, Xuan Wu, Wenzhuo Zhang, Yu Xia and Zhongxiao Wan. Relationship Between Dietary N ε-(carboxymethyl) lysine Intake and Cognitive Function in U.S. Elderly: Data from NHANES 2011-2014. Journal of Food and Nutrition Research. 2023; 11(12):707-714. doi: 10.12691/jfnr-11-12-1

Abstract

To explore the relationship between dietary Nε-(carboxymethyl) lysine (CML) intake and specific cognitive function of the elderly via the National Health and Nutrition Examination Survey (NHANES). A total of 2,321 eligible participants (≥60 years old) of NHANES 2011-2014 were included. Dietary CML intake was calculated via coupling the 24-hour dietary recall questionnaire with developed dietary AGEs database. Cognitive assessment was based on scores from the word learning and recall modules. Logistic regression analyses were conducted to examine the associations between the daily intake of dietary CML and cognitive performance, and stratified analysis according to gender, hypertension and diabetes status was also performed. After adjusting for potential confounders, the dietary CML contents were negatively correlated with the overall cognitive function (OR: 1.43; 95% CI: 1.11,1.85). Compared to those with low dietary CML content, the OR with 95% confidence intervals (CIs) of the risk of overall cognitive impairment in participants in the high dietary CML content group was 2.12 (1.19, 3.77) in those aged 60 to 69 years. The ORs for participants with high dietary CML content at the risk of overall cognitive impairment as well as immediate learning ability were 1.95 (1.19, 3.19) and 1.86 (1.08, 3.22) for those without hypertension, and 1.53 (1.15, 2.03), 1.44 (1.01, 2.05) for those without diabetes, respectively. There was a negative correlation between the dietary CML content and cognitive function in the elderly participants aged 60 years and above in the United States. This effect might be more pronounced in those aged 60 to 69 years, non-hypertensive and non-diabetic participants.

Keywords:
dietary advanced glycation end products Nε-(carboxymethyl) lysine cognitive impairment elderly NHANES

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Collaborators, G.B.D.N., “Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016”, Lancet Neurol, 18 (5), 459-480, May, 2019.
[2]	Eshkoor, S.A., Hamid, T.A., Mun, C.Y.,Ng, C.K., “Mild cognitive impairment and its management in older people”, Clin Interv Aging, 10, 687-693, 2015.
[3]	Akhter, F., Chen, D., Akhter, A., Sosunov, A.A., Chen, A., McKhann, G.M., Yan, S.F.,Yan, S.S., “High Dietary Advanced Glycation End Products Impair Mitochondrial and Cognitive Function”, J Alzheimers Dis, 76 (1), 165-178, 2020.
[4]	Schnaider Beeri, M., Lotan, R., Uribarri, J., Leurgans, S., Bennett, D.A.,Buchman, A.S., “Higher Dietary Intake of Advanced Glycation End Products Is Associated with Faster Cognitive Decline in Community-Dwelling Older Adults”, Nutrients, 14 (7), Mar 31, 2022.
[5]	Perrone, L.,Grant, W.B., “Observational and ecological studies of dietary advanced glycation end products in national diets and Alzheimer's disease incidence and prevalence”, J Alzheimers Dis, 45 (3), 965-979, 2015.
[6]	Shen, C.Y., Lu, C.H., Wu, C.H., Li, K.J., Kuo, Y.M., Hsieh, S.C.,Yu, C.L., “The Development of Maillard Reaction, and Advanced Glycation End Product (AGE)-Receptor for AGE (RAGE) Signaling Inhibitors as Novel Therapeutic Strategies for Patients with AGE-Related Diseases”, Molecules, 25 (23), Nov 27, 2020.
[7]	Yang, S., Zhou, H., Wang, G., Zhong, X.H., Shen, Q.L., Zhang, X.J., Li, R.Y., Chen, L.H., Zhang, Y.H.,Wan, Z., “Quercetin is protective against short-term dietary advanced glycation end products intake induced cognitive dysfunction in aged ICR mice”, J Food Biochem, 44 (4), e13164, Apr, 2020.
[8]	Yang, S., Wang, G., Ma, Z.F., Qin, L.Q., Zhai, Y.J., Yu, Z.L., Xue, M., Zhang, Y.H.,Wan, Z., “DietaryAdvancedGlycationEnd Products-InducedCognitive Impairment in Aged ICR Mice: Protective Role of Quercetin”, Mol Nutr Food Res, 64 (3), e1901019, Feb, 2020.
[9]	Lubitz, I., Ricny, J., Atrakchi-Baranes, D., Shemesh, C., Kravitz, E., Liraz-Zaltsman, S., Maksin-Matveev, A., Cooper, I., Leibowitz, A., Uribarri, J., Schmeidler, J., Cai, W., Kristofikova, Z., Ripova, D., LeRoith, D.,Schnaider-Beeri, M., “High dietary advanced glycation end products are associated with poorer spatial learning and accelerated Abeta deposition in an Alzheimer mouse model”, Aging Cell, 15 (2), 309-316, Apr, 2016.
[10]	Ikeda, K., Higashi, T., Sano, H., Jinnouchi, Y., Yoshida, M., Araki, T., Ueda, S.,Horiuchi, S., “N (epsilon)-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction”, Biochemistry, 35 (24), 8075-8083, Jun 18, 1996.
[11]	Twarda-Clapa, A., Olczak, A., Bialkowska, A.M.,Koziolkiewicz, M., “Advanced Glycation End-Products (AGEs): Formation, Chemistry, Classification, Receptors, and Diseases Related to AGEs”, Cells, 11 (8), Apr 12, 2022.
[12]	Thangthaeng, N., Sumien, N.,Forster, M.J., “Dissociation of functional status from accrual of CML and RAGE in the aged mouse brain”, Exp Gerontol, 43 (12), 1077-1085, Dec, 2008.
[13]	Castellani, R.J., Harris, P.L., Sayre, L.M., Fujii, J., Taniguchi, N., Vitek, M.P., Founds, H., Atwood, C.S., Perry, G.,Smith, M.A., “Active glycation in neurofibrillary pathology of Alzheimer disease: N(epsilon)-(carboxymethyl) lysine and hexitol-lysine”, Free Radic Biol Med, 31 (2), 175-180, Jul 15, 2001.
[14]	Jono, T., Kimura, T., Takamatsu, J., Nagai, R., Miyazaki, K., Yuzuriha, T., Kitamura, T.,Horiuchi, S., “Accumulation of imidazolone, pentosidine and N(epsilon)-(carboxymethyl)lysine in hippocampal CA4 pyramidal neurons of aged human brain”, Pathol Int, 52 (9), 563-571, Sep, 2002.
[15]	Haddad, M., Perrotte, M., Landri, S., Lepage, A., Fulop, T.,Ramassamy, C., “Circulating and Extracellular Vesicles Levels of N-(1-Carboxymethyl)-L-Lysine (CML) Differentiate Early to Moderate Alzheimer's Disease”, J Alzheimers Dis, 69 (3), 751-762, 2019.
[16]	“Food Surveys Research Group: Beltsville, MD”.
[17]	Scheijen, J., Clevers, E., Engelen, L., Dagnelie, P.C., Brouns, F., Stehouwer, C.D.A.,Schalkwijk, C.G., “Analysis of advanced glycation endproducts in selected food items by ultra-performance liquid chromatography tandem mass spectrometry: Presentation of a dietary AGE database”, Food Chem, 190, 1145-1150, Jan 1, 2016.
[18]	Mirmiran, P., Yousefi, R., Mottaghi, A.,Azizi, F., “Advanced glycation end products and risk of hypertension in Iranian adults: Tehran lipid and glucose study”, J Res Med Sci, 23, 43, 2018.
[19]	Li, S., Sun, W.,Zhang, D., “Association of Zinc, Iron, Copper, and Selenium Intakes with Low Cognitive Performance in Older Adults: A Cross-Sectional Study from National Health and Nutrition Examination Survey (NHANES)”, J Alzheimers Dis, 72 (4), 1145-1157, 2019.
[20]	Liu, D., Xie, F., Zeng, N., Han, R., Cao, D., Yu, Z., Wang, Y.,Wan, Z., “Urine caffeine metabolites are positively associated with cognitive performance in older adults: An analysis of US National Health and Nutrition Examination Survey (NHANES) 2011 to 2014”, Nutr Res, 109, 12-25, Jan, 2023.
[21]	Fayemendy, P., Mabiama, G., Vernier, T., Massoulard-Gainant, A., Villemonteix, C., Desport, J.C.,Jésus, P., “Nutritional status, dementia, and mobility among nursing home's residents: First exhaustive cross-sectional study in Limousin territory (France)”, PLoS One, 16 (4), e0250595, 2021.
[22]	“1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee”, J Hypertens, 17 (2), 151-183, Feb, 1999.
[23]	“2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2022”, Diabetes Care, 45 (Suppl 1), S17-s38, Jan 1, 2022.
[24]	Gu, Y., Guo, J.,Moshfegh, A.J., “Race/ethnicity and gender modify the association between diet and cognition in U.S. older adults: National Health and Nutrition Examination Survey 2011-2014”, Alzheimers Dement (N Y), 7 (1), e12128, 2021.
[25]	Southern, L., Williams, J.,Esiri, M.M., “Immunohistochemical study of N-epsilon-carboxymethyl lysine (CML) in human brain: relation to vascular dementia”, BMC Neurol, 7, 35, Oct 16, 2007.
[26]	Tabara, Y., Yamanaka, M., Setoh, K., Segawa, H., Kawaguchi, T., Kosugi, S., Nakayama, T., Matsuda, F.,Nagahama Study, G., “Advanced Glycation End Product Accumulation is Associated with Lower Cognitive Performance in an Older General Population: The Nagahama Study”, J Alzheimers Dis, 74 (3), 741-746, 2020.
[27]	West, R.K., Moshier, E., Lubitz, I., Schmeidler, J., Godbold, J., Cai, W., Uribarri, J., Vlassara, H., Silverman, J.M.,Beeri, M.S., “Dietary advanced glycation end products are associated with decline in memory in young elderly”, Mech Ageing Dev, 140, 10-12, Sep, 2014.
[28]	Zhang, J.H., Xu, H.Z., Shen, Q.F., Lin, Y.Z., Sun, C.K., Sha, L., Ge, Y.S., Liu, Y.,Wang, C., “Nepsilon-(carboxymethyl)-lysine, White Matter, and Cognitive Function in Diabetes Patients”, Can J Neurol Sci, 43 (4), 518-522, Jul, 2016.
[29]	Stirban, A., Negrean, M., Stratmann, B., Gawlowski, T., Horstmann, T., Götting, C., Kleesiek, K., Mueller-Roesel, M., Koschinsky, T., Uribarri, J., Vlassara, H.,Tschoepe, D., “Benfotiamine prevents macro- and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes”, Diabetes Care, 29 (9), 2064-2071, Sep, 2006.
[30]	Zhang, H., Tian, W., Qi, G.,Sun, Y., “Hypertension, dietary fiber intake, and cognitive function in older adults [from the National Health and Nutrition Examination Survey Data (2011-2014)]”, Front Nutr, 9, 1024627, 2022.
[31]	Younessi, P.,Yoonessi, A., “Advanced glycation end-products and their receptor-mediated roles: inflammation and oxidative stress”, Iran J Med Sci, 36 (3), 154-166, Sep, 2011.